U.S. Infrastructure Stock News

Zoom Communications (NasdaqGS:ZM) has rolled out new AI-powered tools for its Virtual Agent platform. The company has also enabled integration with Canary Ambient on the Zoom App Marketplace. These updates expand Zoom's reach in healthcare and customer service automation. Zoom Communications is pushing further into AI driven business tools as it looks beyond its core video conferencing roots. The stock currently trades at $86.445, with the share price up 13.1% over the past year and 3.8%...

If you are wondering whether Vertiv Holdings Co at around US$318 per share still offers value after a strong run, this article breaks down what the current price might be implying. The stock has risen 6.2% over the past week, is down 2.8% over the past month, and shows returns of 81.3% year to date and 160.5% over the past year, with an especially large gain over three years. Recent coverage of Vertiv has focused on the company's role in critical infrastructure for data centers and power...

Earlier in June 2026, EDO announced it was extending its outcomes-based ad measurement into gaming by partnering with Roblox, while Roblox had already globally rolled out new Roblox Kids and Roblox Select accounts introducing stricter age-based controls, age checks, and enhanced parental oversight for users under 16. Together, these moves tighten Roblox’s safeguards for younger players while giving brands TV-like tools to compare immersive Roblox campaigns against broader Convergent TV...

TransMedics Group (TMDX) has drawn fresh attention after a recent share price swing, with the stock rising 7.6% in the latest session and gaining 14.3% over the past month despite weaker multi year returns. See our latest analysis for TransMedics Group. At the current share price of $78.79, TransMedics Group has seen a 30 day share price return of 14.3%, but the year to date share price return is down 35.8% and the 1 year total shareholder return is down 38.2%, even though the 5 year total...

Earlier this month, General Mills expanded its cereal lineup with Honey Nut Cheerios Protein, delivering 8g of protein per serving and supported by a playful “Honey Nuts For You” ring collection and multimedia ad campaign featuring its mascot Buzz. This kind of high-visibility product innovation, blending nutrition messaging with collectible merchandise and pop-culture partnerships, may help reinforce General Mills’ core cereal brands at a time of broader portfolio and margin...

Flutter Entertainment plans to delist from the London Stock Exchange and move to a sole NYSE listing under ticker NYSE:FLUT. The company outlined the intention following a review of trading activity and regulatory considerations. The decision marks a structural shift in how Flutter Entertainment engages with public markets and its shareholder base. Flutter Entertainment is set to concentrate its listing in the US market, with NYSE:FLUT becoming its primary trading venue. The move comes at a...

If you are wondering whether Applied Industrial Technologies is priced attractively after a strong run, the starting point is to separate recent share price excitement from what the underlying valuation actually suggests. The stock last closed at US$330.90, with returns of 2.0% over the past week, 7.7% over the past month, 27.5% year to date and 41.9% over the last year, alongside a very large 3 year gain of 137.3% and a 5 year return of 287.5%. These returns have kept Applied Industrial...

Alliant Energy (LNT) has moved onto some investors’ radar after recent share price gains over the past month and past 3 months. This has prompted a closer look at how the utility stock is positioned. See our latest analysis for Alliant Energy. Beyond the recent monthly gains, Alliant Energy’s recent share price momentum has been steady, with a 90 day share price return of 6.88% and year to date share price return of 13.69% supporting a 1 year total shareholder return of 25.75% and 3 year...

The temporary US waiver on Iranian oil sanctions is shaking up expectations around energy supply, shipping routes, and feedstock costs, and that matters directly for chemicals and industrial materials stocks. When oil, gas, and petrochemical flows shift, so do input prices and competitive positions. For investors, this creates a window to reassess which companies might benefit from easier access to feedstocks or smoother trade, and which could face new pricing pressures. This article walks...

Aptiv (APTV) is back in focus after robotics company Robust.AI chose its PULSE sensor and AI based perception stack to power the Gen 3 Carter collaborative mobile robot in warehouse environments. See our latest analysis for Aptiv. Despite the new robotics partnership and Aptiv’s presence at the Automate 2026 conference, short term momentum has been weak, with the share price down 21.7% year to date and the 3 year total shareholder return down 27.9%. If this robotics news has you thinking...

Primoris Services (NYSE:PRIM) sharply cut its 2026 profit and renewables revenue guidance. The company reported persistent cost overruns and project delays in its Renewables segment. Primoris Services announced the sudden departure of its Chief Operating Officer. Multiple law firms have launched investigations following a steep share price drop. Primoris Services (NYSE:PRIM) is under pressure after a sharp reset to its 2026 earnings outlook and renewables revenue guidance, combined with the...

Fiserv (FISV) is back in focus after recent trading left the stock down about 17% over the past month and about 16% over the past 3 months, which has sharpened attention on its current valuation. See our latest analysis for Fiserv. Stepping back, Fiserv’s recent slide fits into a longer weak patch, with the share price down 27.9% year to date and the 1 year total shareholder return declining 72.6%. This points to fading momentum and a more cautious market view on its risk and growth...

uniQure (NasdaqGS:QURE) reported positive initial data from its Phase I/IIa trial of AMT-260 for refractory mesial temporal lobe epilepsy. Several patients in the initial low dose cohort experienced meaningful seizure reduction, with an encouraging safety profile. This is the first clinical efficacy and safety readout for AMT-260, expanding uniQure's pipeline beyond Huntington's disease. uniQure, trading at $49.04, is drawing fresh attention as AMT-260 moves from concept to early clinical...

Vicor stock performance puts spotlight on recent returns Vicor (VICR) has drawn fresh attention after a sharp move in the share price, with the stock up about 25% over the past month and about 81% over the past 3 months. That short term performance sits alongside a year to date total return of about 188% and an approximate 641% total return over the past year. This is prompting investors to reassess how current fundamentals align with the new share price. See our latest analysis for Vicor. At...

International Business Machines (NYSE:IBM) has joined OpenAI's Daybreak Cyber Partner Program to deliver enterprise AI powered cybersecurity solutions. The partnership focuses on software risk management and open source security for large organizations. In parallel, the U.S. government has issued executive orders to accelerate quantum technology and require a shift to post quantum cryptography, citing IBM's role in these fields. International Business Machines enters this news cycle with a...

Leidos Holdings (LDOS) has attracted fresh attention after securing new roles in the ExCURSion energy program with DARPA and landing four awards under the U.S. Department of State’s Evolve IT modernization contract. See our latest analysis for Leidos Holdings. Despite the new DARPA and Evolve contract roles, Leidos Holdings’ share price has come under pressure, with the 30 day share price return down 15.79% and the year to date share price return down 42.16%. Over the same period, the 3 year...

Enterprise Products Partners (EPD) is drawing fresh attention after recent analyst estimate revisions highlighted rising confidence ahead of its upcoming earnings report, where year-over-year growth in both earnings and revenue is currently expected. See our latest analysis for Enterprise Products Partners. At a share price of US$37.13, Enterprise Products Partners has seen a 1-day share price return of 1.95% and a 7-day share price return of 1.87%, while the 30-day share price return is down...

Recent Share Performance Context Kosmos Energy (KOS) has drawn attention after its stock fell 24% over the past month and 14% over the past 3 months, while its year-to-date return remains positive. See our latest analysis for Kosmos Energy. The recent slide in Kosmos Energy’s share price, including a 6.5% decline on the day and a 7.6% fall over the past week, comes after a very strong year to date share price return of 157.6%. The 1 year total shareholder return of 18.6% sits against weaker 3...

AT&T Fiber was named the top home internet provider in a recent Opensignal report. The service outperformed peers on speed, reliability, and video quality metrics. The recognition highlights outcomes from AT&T’s multi year investment in fiber infrastructure. For investors tracking NYSE:T, this third party endorsement focuses attention on AT&T’s consumer internet offering rather than its traditional telecom operations. The stock last closed at $22.81, with the share price down 9.7% over the...

Talphera, Inc. ( NASDAQ:TLPH ) insiders who bought shares over the past year were rewarded handsomely last week. The...

Insiders who acquired US$611.2k worth of Sintx Technologies, Inc.'s ( NASDAQ:SINT ) stock at an average price of...

Last week, DiaMedica Therapeutics Inc. ( NASDAQ:DMAC ) insiders, who had purchased shares in the previous 12 months...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Boston Scientific’s Watchman heart device is increasingly being implanted during combined cardiac procedures instead of as a standalone treatment. This shift in medical practice has reduced standalone Watchman procedure volumes and is expected to keep revenue for the product line roughly flat through Q3 2026. The change reflects how doctors are rethinking procedure planning, with implications for Boston Scientific’s growth mix and product planning. For investors watching Boston Scientific...